Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze-Yang Ding

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Pharmacological Research|March 23, 2023
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolismQiang Wang, Shiyou Li, Chen Xu, et al.
Cell Communication and Signaling : CCS|March 18, 2014
Activin A induces growth arrest through a SMAD- dependent pathway in hepatic progenitor cellsLin Chen, Wei Zhang, Hui-fang Liang, et al.
International Journal of Molecular Sciences|March 25, 2016
Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor CellsZe-Yang Ding, Guan-Nan Jin, Wei Wang, et al.
Gut|December 20, 2023
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8<sup>+</sup> T cell-mediated antitumour immunity and improves anti-PD-1 efficacyNing Cai, Kun Cheng, Yue Ma, et al.
Oncotarget|March 20, 2016
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinomaWei-Xun Chen, Zhan-Guo Zhang, Ze-Yang Ding, et al.
Journal of Nanobiotechnology|July 10, 2026
Mechano-reprogramming of tumor-associated macrophages by engineering nanogel stiffness for suppression of tumor developmentHaochen Lin, Zheng Li, Ao Hua, et al.
Clinical and Translational Medicine|November 29, 2021
GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinomaQian Yun Ge, Jin Chen, Gan Xun Li, et al.
Scientific Reports|October 10, 2015
Despair-associated memory requires a slow-onset CA1 long-term potentiation with unique underlying mechanismsLiang Jing, Ting-Ting Duan, Meng Tian, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Kidney International|July 23, 2023
Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosisChaoyi Yuan, Guannan Jin, Pengcheng Li, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Pharmacological Research|March 23, 2023
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolismQiang Wang, Shiyou Li, Chen Xu, et al.
Cell Communication and Signaling : CCS|March 18, 2014
Activin A induces growth arrest through a SMAD- dependent pathway in hepatic progenitor cellsLin Chen, Wei Zhang, Hui-fang Liang, et al.
International Journal of Molecular Sciences|March 25, 2016
Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor CellsZe-Yang Ding, Guan-Nan Jin, Wei Wang, et al.
Gut|December 20, 2023
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8<sup>+</sup> T cell-mediated antitumour immunity and improves anti-PD-1 efficacyNing Cai, Kun Cheng, Yue Ma, et al.
Oncotarget|March 20, 2016
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinomaWei-Xun Chen, Zhan-Guo Zhang, Ze-Yang Ding, et al.
Journal of Nanobiotechnology|July 10, 2026
Mechano-reprogramming of tumor-associated macrophages by engineering nanogel stiffness for suppression of tumor developmentHaochen Lin, Zheng Li, Ao Hua, et al.
Clinical and Translational Medicine|November 29, 2021
GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinomaQian Yun Ge, Jin Chen, Gan Xun Li, et al.
Scientific Reports|October 10, 2015
Despair-associated memory requires a slow-onset CA1 long-term potentiation with unique underlying mechanismsLiang Jing, Ting-Ting Duan, Meng Tian, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Kidney International|July 23, 2023
Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosisChaoyi Yuan, Guannan Jin, Pengcheng Li, et al.
Pageof 5